威海廣泰(002111.SZ):上半年新簽訂單13.22億元 同比增31.87%
格隆匯7月3日丨威海廣泰(002111.SZ)公佈,2020年1-6月,公司累計簽訂訂單金額約為13.22億元(不含已中標尚未簽訂合同的金額),較2019年同期增長31.87%。截至2020年6月30日,公司在手訂單總金額約為26.09億元(含已中標尚未簽訂合同金額)。
公司表示,公司緊抓軍工業務的發展機遇,堅持“以客户價值為導向,走精品道路,提質降本增效”的經營方針,不斷深耕現有市場、拓展新市場和業務領域,取得了積極成效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.